Weili Jin

444 total citations
12 papers, 328 citations indexed

About

Weili Jin is a scholar working on Cancer Research, Molecular Biology and Epidemiology. According to data from OpenAlex, Weili Jin has authored 12 papers receiving a total of 328 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cancer Research, 7 papers in Molecular Biology and 3 papers in Epidemiology. Recurrent topics in Weili Jin's work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (3 papers) and Barrier Structure and Function Studies (2 papers). Weili Jin is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (3 papers) and Barrier Structure and Function Studies (2 papers). Weili Jin collaborates with scholars based in China and Portugal. Weili Jin's co-authors include Chunsheng Kang, Yanli Tan, Qixue Wang, Junhu Zhou, Yunfei Wang, Jixing Zhao, Kaikai Yi, Ye Wu, Eryan Yang and Fei Tong and has published in prestigious journals such as Frontiers in Immunology, BMC Medicine and Theranostics.

In The Last Decade

Weili Jin

11 papers receiving 326 citations

Peers

Weili Jin

MB

CR

PRM

NEURO

GENET

Zhengtao Yu China

Hongbo Bao China

Yadi Xu China

Jixing Zhao China

Tianfang Chang China

Roberto Navarro Quiroz Colombia

Changlin Lian China

Xihe Zhao China

Rebecca G. Anderson United States

Can Yang China

Zhengtao Yu China

Weili Jin

201 ×0.8

MB

104 ×0.6

CR

45 ×1.1

PRM

37 ×1.0

NEURO

12 ×0.4

GENET

Citations per year, relative to Weili Jin Weili Jin (= 1×) peers Zhengtao Yu

Countries citing papers authored by Weili Jin

Since Specialization

Citations

This map shows the geographic impact of Weili Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weili Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weili Jin more than expected).

Fields of papers citing papers by Weili Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weili Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weili Jin. The network helps show where Weili Jin may publish in the future.

Co-authorship network of co-authors of Weili Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Weili Jin. A scholar is included among the top collaborators of Weili Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weili Jin. Weili Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Xu, Qingsheng, Kaiyuan Huang, Luqing Tong, et al.. (2025). Intrathecal pemetrexed efficacy and cerebrospinal fluid tumor marker response in refractory leptomeningeal metastasis of non-small-cell lung cancer: a single-arm phase II trial. BMC Medicine. 23(1). 301–301.

2.

Luo, Meng, Yao Jin, Chunjing Xu, et al.. (2023). Postmastectomy radiotherapy in patients with T1-2N1 breast cancer: a single center experience and a meta-analysis. Journal of Cancer Research and Clinical Oncology. 149(12). 9979–9990. 1 indexed citations

3.

Yang, Eryan, Lin Wang, Weili Jin, et al.. (2022). PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma. Theranostics. 12(9). 4330–4347. 27 indexed citations

4.

Jin, Weili, Jixing Zhao, Eryan Yang, et al.. (2022). Neuronal STAT3/HIF-1α/PTRF axis-mediated bioenergetic disturbance exacerbates cerebral ischemia-reperfusion injury via PLA2G4A. Theranostics. 12(7). 3196–3216. 61 indexed citations

5.

Miao, Da, Hao Jiang, Yangyang Xie, Weili Jin, & Shuwen Han. (2021). The Biological Roles of Exosomal Long Non-Coding RNAs in Cancers. OncoTargets and Therapy. Volume 14. 271–287. 14 indexed citations

6.

Wang, Yunfei, Kaikai Yi, Xing Liu, et al.. (2021). HOTAIR Up-Regulation Activates NF-κB to Induce Immunoescape in Gliomas. Frontiers in Immunology. 12. 785463–785463. 31 indexed citations

7.

Jin, Weili, Ye Wu, Ning Chen, et al.. (2021). Early administration of MPC-n(IVIg) selectively accumulates in ischemic areas to protect inflammation-induced brain damage from ischemic stroke. Theranostics. 11(17). 8197–8217. 17 indexed citations

8.

Zhao, Jixing, Weili Jin, Kaikai Yi, et al.. (2021). Combination LSD1 and HOTAIR-EZH2 inhibition disrupts cell cycle processes and induces apoptosis in glioblastoma cells. Pharmacological Research. 171. 105764–105764. 45 indexed citations

9.

Wang, Heng, et al.. (2021). High Expression of SLC41A3 Correlates with Poor Prognosis in Hepatocellular Carcinoma. OncoTargets and Therapy. Volume 14. 2975–2988. 9 indexed citations

10.

Li, Yansheng, Yu Ren, Yunfei Wang, et al.. (2019). A Compound AC1Q3QWB Selectively Disrupts HOTAIR-Mediated Recruitment of PRC2 and Enhances Cancer Therapy of DZNep. Theranostics. 9(16). 4608–4623. 84 indexed citations

11.

Yang, Eryan, Ying Cai, Xiuhua Yao, et al.. (2019). Tissue plasminogen activator disrupts the blood-brain barrier through increasing the inflammatory response mediated by pericytes after cerebral ischemia. Aging. 11(22). 10167–10182. 23 indexed citations

12.

Wang, Qixue, Yanli Tan, Chuan Fang, et al.. (2019). Single-cell RNA-seq reveals RAD51AP1 as a potent mediator of EGFRvIII in human glioblastomas. Aging. 11(18). 7707–7722. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact